Intravaginal and intrarectal screening of antimitotic drugs for topical effectiveness.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D003078:Colchicine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006918:Hydroxyurea / Q000008:administration & dosage; D007413:Intestinal Mucosa / Q000187:drug effects; D008466:Mechlorethamine / Q000008:administration & dosage; D008722:Methods; D008727:Methotrexate / Q000008:administration & dosage; D051379:Mice; D008938:Mitosis / Q000187:drug effects*; D009092:Mucous Membrane / Q000187:drug effects; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D011033:Podophyllin / Q000008:administration & dosage; D012007:Rectum / Q000187:drug effects* / Q000473:pathology; D014621:Vagina / Q000187:drug effects* / Q000473:pathology; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D003561:Cytarabine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D011033:Podophyllin; D003078:Colchicine; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate; D003630:Daunorubicin